Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2), is a heterogenic and aggressive subtype of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.